Israel Institute for Biological Research announces that its COVID-19 vaccine candidate will be named as Brilife,
The Israel Institute for Biological Research announces that its COVID-19 vaccine candidate will be named as Brilife, with phase 1 human trails expected to start during the end of the month.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
NewsIsrael Institute for Biological Research announces that its COVID-19 vaccine candidate will be named as Brilife,
View Premium plansBrowse free archive reportsThe Israel Institute for Biological Research announces that its COVID-19 vaccine candidate will be named as Brilife, with phase 1 human trails expected to start during the end of the month.